Reggiani, Francesco
 Distribuzione geografica
Continente #
NA - Nord America 1.835
AS - Asia 1.302
EU - Europa 438
SA - Sud America 188
Continente sconosciuto - Info sul continente non disponibili 92
AF - Africa 32
OC - Oceania 4
Totale 3.891
Nazione #
US - Stati Uniti d'America 1.762
SG - Singapore 719
CN - Cina 317
IT - Italia 198
BR - Brasile 140
VN - Vietnam 125
HK - Hong Kong 46
CA - Canada 31
DE - Germania 30
FI - Finlandia 30
IE - Irlanda 29
IN - India 26
GB - Regno Unito 25
MK - Macedonia 21
AR - Argentina 19
FR - Francia 19
MX - Messico 19
NL - Olanda 17
PL - Polonia 13
BD - Bangladesh 12
PH - Filippine 10
RU - Federazione Russa 8
TR - Turchia 8
UA - Ucraina 8
CO - Colombia 7
CR - Costa Rica 7
EC - Ecuador 7
ES - Italia 7
NG - Nigeria 7
ZA - Sudafrica 7
PK - Pakistan 6
AT - Austria 5
JP - Giappone 5
MA - Marocco 5
PE - Perù 5
TN - Tunisia 5
AU - Australia 4
CL - Cile 4
IQ - Iraq 4
LV - Lettonia 4
SA - Arabia Saudita 4
SE - Svezia 4
BB - Barbados 3
EE - Estonia 3
HU - Ungheria 3
VE - Venezuela 3
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
CH - Svizzera 2
ET - Etiopia 2
GR - Grecia 2
HN - Honduras 2
ID - Indonesia 2
IL - Israele 2
JM - Giamaica 2
JO - Giordania 2
KR - Corea 2
LT - Lituania 2
PY - Paraguay 2
AG - Antigua e Barbuda 1
AL - Albania 1
AM - Armenia 1
BG - Bulgaria 1
BS - Bahamas 1
BY - Bielorussia 1
DZ - Algeria 1
EG - Egitto 1
GD - Grenada 1
GT - Guatemala 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MU - Mauritius 1
MY - Malesia 1
NI - Nicaragua 1
PA - Panama 1
PR - Porto Rico 1
PT - Portogallo 1
RS - Serbia 1
SI - Slovenia 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UG - Uganda 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 3.799
Città #
Singapore 340
San Jose 233
Ashburn 208
Shanghai 119
Beijing 98
The Dalles 96
Council Bluffs 85
Dallas 77
Boardman 72
Milan 69
New York 52
Santa Clara 49
Los Angeles 46
Ho Chi Minh City 44
Hong Kong 44
Hanoi 31
Helsinki 30
Dublin 28
Phoenix 27
Chandler 26
Rome 26
Naples 25
Wilmington 17
São Paulo 14
Atlanta 13
Brooklyn 13
Montreal 10
Rio de Janeiro 10
Warsaw 10
Washington 10
Chicago 9
Houston 9
Orem 9
Princeton 9
Skopje 9
Boston 8
Buffalo 8
Mexico City 8
Orlando 8
Paris 8
Amsterdam 7
Charlotte 7
London 7
Seattle 7
Benin City 6
Bitola 6
Chennai 6
Frankfurt am Main 6
Haiphong 6
Jacksonville 6
Philadelphia 6
San Francisco 6
Tampa 6
Cusco 5
Da Nang 5
Fort Worth 5
Istanbul 5
Katy 5
Lawrence 5
North Bergen 5
San José 5
San Mateo 5
The Bronx 5
Tokyo 5
Assago 4
Denver 4
Detroit 4
Johannesburg 4
Mumbai 4
Pasadena 4
Queens 4
Redwood City 4
Riga 4
Toronto 4
Worcester 4
Abbeville 3
Buenos Aires 3
Colorado Springs 3
Columbus 3
Converse 3
Falkenstein 3
Figino 3
Hải Dương 3
Indianapolis 3
Las Vegas 3
Medellín 3
Newark 3
Ninh Bình 3
Nuremberg 3
Olongapo City 3
Prilep 3
Prineville 3
Pune 3
Rabat 3
Riverside 3
Rochester 3
Springfield 3
Sydney 3
Turin 3
Youngstown 3
Totale 2.263
Nome #
Outcome of Sars-COV-2-related thyrotoxicosis in survivors of Covid-19: a prospective study 232
Genomewide Association Study of Severe Covid-19 with Respiratory Failure 150
Long-term kidney outcome of patients with rheumatological diseases and antineutrophil cytoplasmic antibody-glomerulonephritis: comparison with a primitive ANCA-glomerulonephritis cohort 149
Herpes zoster in lupus nephritis: experience on 292 patients followed up for 15 years 98
Beyond ISN/RPS Lupus Nephritis Classification: Adding Chronicity Index to Clinical Variables Predicts Kidney Survival 89
Impact of chronic exposure to 5-alpha reductase inhibitors on the risk of hospitalization for COVID-19: a case-control study in male population from two COVID-19 regional centers of Lombardy, Italy 85
Comparative Analysis of Antithrombotic Therapy Outcomes in Mild Traumatic Brain-Injury Patients: A Focus on Bleeding Risk and Hospital-Stay Duration 84
Delayed Graft Function in Kidney Transplant: Risk Factors, Consequences and Prevention Strategies 84
Changing Phenotypes and Clinical Outcomes Over Time in Microscopic Polyangiitis 83
Low testosterone predicts hypoxemic respiratory insufficiency and mortality in patients with COVID-19 disease: another piece in the COVID puzzle 81
Goodpasture syndrome and anti-glomerular basement membrane disease 79
Renal sarcoidosis 79
A phase 2 randomized, double-blinded, placebo-controlled, multicenter trial evaluating the efficacy and safety of raloxifene for patients with mild to moderate COVID-19 75
Autosomal Dominant Polycystic Kidney Disease: Is There a Role for Autophagy? 74
Anti-C1q antibodies: a biomarker for diagnosis and management of lupus nephritis. A narrative review 74
Cardiovascular Risk after Kidney Transplantation: Causes and Current Approaches to a Relevant Burden 72
Prevalence and clinical significance of ANCA positivity in lupus nephritis: a case series of 116 patients and literature review 72
Effect of Sustained Clinical Remission on the Risk of Lupus Flares and Impaired Kidney Function in Patients With Lupus Nephritis 70
Assessment of malnutrition risk in post-stroke patients: a systematic literature review 67
Blood Thiol Redox State in Chronic Kidney Disease 66
Drug Prescription and Delirium in Older Inpatients: Results From the Nationwide Multicenter Italian Delirium Day 2015-2016 65
Monoclonal gammopathy in lupus nephritis 62
The value of the current histological scores and classifications of ANCA glomerulonephritis in predicting long-term outcome 62
Assessment of glutathione/glutathione disulphide ratio and S-glutathionylated proteins in human blood, solid tissues, and cultured cells 61
Kinetics of the Cell Cycle Arrest Biomarkers (TIMP2 and IGFBP7) for the Diagnosis of Acute Kidney Injury in Critically Ill COVID-19 Patients 61
Subjective Global Assessment-Dialysis Malnutrition Score and cardiovascular risk in hemodialysis patients: an observational cohort study 58
Plasma protein carbonyls as biomarkers of oxidative stress in chronic kidney disease, dialysis, and transplantation 58
Anti-C1Q monitoring predicts relapses of lupus nephritis 58
Dysphagia screening post-stroke: systematic review 58
Predictors of increase in chronicity index and of kidney function impairment at repeat biopsy in lupus nephritis 57
Autophagy: A Silent Protagonist in Kidney Transplantation 57
Advanced oxidation protein products in nondiabetic end stage renal disease patients on maintenance haemodialysis 57
Renal involvement in eosinophilic granulomatosis with polyangiitis 56
Integrated protocol for the prevention and treatment of skin ulcers in patients with end-stage renal disease 55
Plasma protein-bound di-tyrosines as biomarkers of oxidative stress in end stage renal disease patients on maintenance haemodialysis 54
Hospital Malnutrition in the Medicine and Neurology Departments: A Complex Challenge 53
Enhancing clinical nutrition education for healthcare professionals: Engagement through active learning methodologies 52
HCV-negative mixed cryoglobulinemic glomerulonephritis and solid malignancy: A case report and review of the literature 52
Old and new calcineurin inhibitors in lupus nephritis 52
Ursodeoxycholic Acid Does Not Improve COVID-19 Outcome in Hospitalized Patients 52
Neurological Counterparts of Hyponatremia: Pathological Mechanisms and Clinical Manifestations 51
Impact of Mayo Adhesive Probability score and BMI on renal functional decline after robotic assisted partial nephrectomy 51
Preliminary experience on the use of sucrosomial iron in hemodialysis: focus on safety, hemoglobin maintenance and oxidative stress 50
Focal segmental glomerular sclerosis: do not overlook the role of immune response 49
Switching Patients with Type 1 Diabetes to Insulin Degludec from Other Basal Insulins: Real-World Data of Effectiveness and Safety 49
Treatment strategies for ANCA-associated vasculitides: from standard protocols to future horizons 48
Impact of Insulin Degludec in Type 2 Diabetes: Real-World Data on Effectiveness and Safety 45
Autophagy and podocytopathy 44
Plasma protein thiolation index (PTI) as a biomarker of thiol-specific oxidative stress in haemodialyzed patients 44
Plasma protein carbonylation in haemodialysed patients: Focus on diabetes and gender 43
Erdheim-Chester disease: From palliative care to targeted treatment 43
Kidney Involvement in Systemic Sclerosis 42
Improvement of Erdheim-Chester disease-related renal failure after treatment with anakinra 41
Immune-mediating and immunosuppressive pharmacotherapies for proliferative lupus nephritis 34
Clinical presentation, outcomes and risk of relapses of lupus podocytopathy in a multicentre Italian cohort 34
Predictors of Long-term Response in Patients With Lupus Nephritis 27
Isolated C3 hypocomplementemia as an early predictor of chronic kidney disease in lupus nephritis 25
Pain, quality of life, work ability and psychosocial well-being in living kidney donors: A scoping review 24
Clinical and immunological biomarkers can identify proliferative changes and predict renal flares in lupus nephritis 23
Diagnostic challenge of high vitamin B12 levels: a case report and review of the literature 20
Malignancies in lupus nephritis: a retrospective cohort study on epidemiology and risk factors 19
Different clusters in patients with lupus podocytopathy identified by clinical-pathological characteristics 17
Editorial: Exploring the impact of biologics in nephrology: clinical advances and future perspectives 17
Scaling up frailty: psychometric validation of the functional limitations and geriatric syndromes frailty questionnaire—a new tool for uniformly classifying vulnerable hospital patients 17
Long-term prognosis of lupus nephritis: comparison between pediatric, adult, and advanced age onset 16
Three years is the minimal effective duration of sustained clinical remission which prevents impaired kidney function and damage accrual in lupus nephritis 15
Totale 3.891
Categoria #
all - tutte 21.931
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.931


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202224 0 0 0 3 0 0 1 3 1 4 11 1
2022/2023126 9 3 7 4 9 9 4 8 27 7 8 31
2023/2024464 38 12 69 48 20 47 61 44 17 9 40 59
2024/2025732 6 36 19 16 10 55 28 84 98 162 116 102
2025/20261.685 222 103 65 121 104 107 446 107 76 135 91 108
2026/2027807 162 169 385 91 0 0 0 0 0 0 0 0
Totale 3.891